Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants Requiring Mechanical Ventilation or Positive Pressure Support on Days 5-14 After Birth

NCT00931632 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.

NCT NCT00931632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00931632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants Requiring Mechanical Ventilation or Positive Pressure Support on Days 5-14 After Birth
Lead sponsor
Mallinckrodt
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2009
Completion date
May 31, 2014
Enrollment
451 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia